21022 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof Oxidoreductases (1)
Methods of disinfecting packages in aseptic packaging using antimicrobial peracid compositions with selected catalase enzymes
#602Agent for use in the case of fructose intolerance
#603Metallo-lactoferrin-coenzyme compositions and methods for weight management
#604Metallo-lactoferrin-coenzyme compositions for detoxification support
#605Bacterial nitroreductase enzymes and methods relating thereto
#606Stabilisation of Proteins
#607ANTIFUNGAL COMPOSITION
#608Silk microspheres for encapsulation and controlled release
#609Adeno-associated virus vector for gene transfer to nervous system cells
#610Method of deriving mature hepatocytes from human embryonic stem cells
#611Compositions comprising glutathione reductase and oxidized glutathione
#612Product and process for liquefaction of mucus or sputum
#613Expression vector for cholesterol 24-hydrolase in therapy of Huntington's disease
#614Agent for use in the case of fructose intolerance
#615Agent for use in the case of fructose intolerance
#616Mobilization of hematopoietic stem cells
#617MODULATION OF NITRIC OXIDE SIGNALING TO NORMALIZE TUMOR VASCULATURE
#618PERORALLY APPLICABLE PREPARATION CONTAINING HISTAMINASE OF VEGETABLE ORIGIN, RESISTANT TO PEPSIN AND TRYPSIN AND A PROCESS FOR PRODUCING IT
#619Vectors Conditionally Expressing Therapeutic Proteins, Host Cells Comprising the Vectors, and Uses Thereof
#620Methods and compositions for cell-proliferation-related disorders
#621COMPOSITIONS AND METHODS FOR INHIBITING VIRAL INFECTION
#622METHOD FOR CONTROLLING CONTINUOUSNESS OF DEODORANT EFFECT AFTER CONSUMPTION OF CHEWING GUM COMPOSITION AND A CHEWING GUM COMPOSITION
#623HIFα hydroxylation assay
#624Methods and compositions for treating oxalate-related conditions
#625Compositions and methods for treatment of vitiligo
#626METHOD OF PRODUCING A HYDROGEL
#627AGENT FOR REDUCING ACETALDEHYDE IN ORAL CAVITY
#628Methods for assisting anti-cancer drugs
#629Variant form of urate oxidase and use thereof
#630Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system
#631Method of improving diastolic dysfunction
#632COMPOSITIONS AND METHODS FOR PRODUCING ANTIGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS WITH SYNTHETIC NANOCARRIERS
#633INDUCED TOLEROGENIC DENDRITIC CELLS FOR INDUCING REGULATORY B CELLS
#634COMPOSITIONS AND METHODS RELATED TO INDUCED TOLEROGENIC DENDRITIC CELLS EXTERNALLY LOADED WITH MHC CLASS I-RESTRICTED EPITOPES
#635ALLERGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS FOR ALLERGY THERAPY
#636ANTIGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS TO REDUCE ANTIBODY RESPONSES
#637ANTIGEN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS TO REDUCE CYTOTOXIC T LYMPHOCYTE RESPONSES
#638INDUCED TOLEROGENIC DENDRITIC CELLS TO REDUCE SYSTEMIC INFLAMMATORY CYTOKINES
#639INDUCED TOLEROGENIC DENDRITIC CELLS FOR GENERATING CD8+ REGULATORY T CELLS
#640DENDRITIC CELL SUBSETS FOR GENERATING INDUCED TOLEROGENIC DENDRITIC CELLS AND RELATED COMPOSITIONS AND METHODS
#641TRANSPLANTABLE GRAFT-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS AND METHODS OF USE
#642THERAPEUTIC PROTEIN-SPECIFIC INDUCED TOLEROGENIC DENDRITIC CELLS AND METHODS OF USE
#643Compositions and Methods for the Treatment of Lung Inflammation
#644Treating glaucoma, cardiovascular diseases, and renal diseases
#645DIAGNOSIS AND TREATMENT OF MULTIPLE SULFATASE DEFICIENCY AND OTHER SULFATASE DEFICIENCIES
#646Methods For High Density Lipoprotein Cholesterol Regulation
#647Stimulation of the synthesis of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers
#648Methods for Treating Inflammation and Oxidative Stress Related Diseases
#649Artificial saliva comprising hyaluronic acid
#650Methods of disinfecting packages in aseptic packaging using antimicrobial peracid compositions with selected catalase enzymes
#651ANTIBACTERIAL AUXILIARY AGENT COMPRISING KOMBU EXTRACT AS ACTIVE INGREDIENT, ANTIBACTERIAL COMPOSITION, AND FOOD OR BEVERAGE
#652Variant forms of urate oxidase and use thereof
#653Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
#654METHOD OF DELIVERING OXYGEN USING PEG-HEMOGLOBIN CONJUGATES WITH ENHANCED NITRITE REDUCTASE ACTIVITY
#655Variant form of urate oxidase and use thereof
#656METHODS OF TREATING INFLAMMATION BY ADMINISTRATION OF HEME OXYGENASE-1 AND PRODUCTS OF HEME DEGRADATION
#657STABLE AQUEOUS SUSPENSION
#658BIOMARKERS AND THERAPEUTIC TARGETS FOR TYPE 1 DIABETES
#659ORAL DISINFECTANT, AND FOOD ADDITIVE COMPRISING THE DISINFECTANT
#660COMPOSITIONS CONTAINING INCLUSION COMPLEXES
#661Lipoxygenase and its use in wound healing
#662Use of Inclusion Bodies as Therapeutic Agents
#663Targeted therapeutic proteins
#664Polymer Conjugates with Decreased Antigenicity, Methods of Preparation and Uses Thereof
#665USE OF IL-1 ANTAGONISTS TO TREAT PSEUDOGOUT
#666Combination therapy using coenzyme Q10 and a caffeic acid-derived ester
#667CORNEAL TREATMENT SYSTEM AND METHOD
#668Variant form of urate oxidase and use thereof
#669Composition for oral health treatment and related methods of use
#670Method of screening for a substance that strengthens a bond between thioredoxin and macrophage migration inhibition factor
#671Composition Comprising Vascular Endothelial Growth Factor (VEGF) for the Treatment of Hair Loss
#672Soothing pharmaceutical or cosmetic composition comprising a peptide that activates HMG-CoA reductase
#673Vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#674USE OF HAPTOGLOBIN GENOTYPING IN DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASE
#675Dietary composition and method for promoting healthy hair growth and melanogenesis
#676Methods of diagnosing and treating fibrosis
#677Antimicrobial peracid compositions with selected catalase enzymes and methods of use in aseptic packaging
#678PHARMACEUTICAL COMPOSITION, FOOD OR DRINK, OR FEED FOR INTESTINAL DISEASE
#679Complexing agents for compositions containing inclusion complexes
#680Method for the preventing and/or treating IL-1 beta lung pathology in mammals by administering a uric acid reducing compound
#681Cell therapy for the treatment of lysosomal storage disorders
#682TOPICAL ANTI-INFLAMMATORY COMPOSITION
#683Enhanced lactoperoxidase system for treatment of milk products
#684Variant form of urate oxidase and use thereof
#685Use of human Biliverdin reductase and fragments thereof protein kinase C-δ and ERK related conditions
#686MAMMALIAN HYPOTHALAMIC NUTRIENT MODULATION OF GLUCOSE METABOLISM
#687Metallo-lactoferrin-coenzyme compositions to improve sleep patterns
#688In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#689In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#690METHODS OF TREATING HEMORHEOLOGIC ABNORMALITIES IN MAMMALS
#691Compositions containing inclusion complexes
#692Inhibition of Tumor Angiogenesis by Inhibition of Peroxiredoxin 1 (PRX1)
#693METHODS AND COMPOSITIONS FOR TREATMENT OF MITOCHONDRIAL DISORDERS
#694URICASE COMPOSITIONS AND METHODS OF USE
#695PROTOCOLS FOR TREATING AND PREVENTING OBESITY AND COMPLICATIONS ARISING THEREFROM
#696Novel Herbal Composition for Treatment of Psoriasis and Other Skin Disorders
#697Treatment Using Herpes Simplex Virus
#698COMPOSITIONS AND METHODS FOR TREATMENT OF VITILIGO
#699MYCOTOXIN-REDUCING COMPOSITION
#700Compositions and methods for reprogramming eukaryotic cells
#701Methods and compositions for treating phenylketonuria
#702Nitric Oxide Compositions and Devices and Methods for Cosmesis
#703Variant form of urate oxidase and use thereof
#704Nitric Oxide Device and Method for Wound Healing, Treatment of Dermatological Disorders and Microbial Infections
#705Polysaccharide-protein conjugates reversibly coupled via imine bonds
#706METHODS OF REGULATING RENALASE (MONOAMINE OXIDASE C)
#707Methods of attaching a molecule-of-interest to a microtube
#708Methods of treating cancer of the central nervous system
#709USE OF HYDROLYTIC AND OXIDATIVE ENZYMES TO DISSOLVE BIOFILM IN AIRWAY PASSAGES
#710Method of attaching a cell-of-interest to a microtube
#711CYP46A1 gene for the treatment of alzheimer's disease
#712Stabilisation of Proteins
#713PROTEINS EZRIN, SERPIN B5, PEROXIREDOXIN-2 AND HEAT SHOCK PROTEIN BETA-1 AS AUTOANTIGENS FOR PSORIASIS VULGARIS AND POSTSTREPTOCOCCAL DISEASES
#714Use of electrospun microtubes for drug delivery
#715Treatment of osteoporosis
#716Mobilization of hematopoietic stem cells
#717STIMULATION OF THE SYNTHESIS OF THE ACTIVITY OF AN ISOFORM OF LYSL OXIDASE-LIKE LOXL FOR STIMULATING THE FORMATION OF ELASTIC FIBRES
#718Lysozyme, A Novel Vasodilator of Sepsis that can be inhibited by a Peroxidase and Hydroxyl Radical Scavengers
#719Compositions and methods for the treatment of cancer
#720Use of IL-1 antagonists to treat gout
#721Treatment Method
#722Diaminooxidase-containing pharmaceutical compositions
#723NOVEL METHODS AND MEDICAMENT FOR TREATING INFECTIOUS DISEASES INVOLVING MICROBIAL BIOFILMS
#724PROPHYLATIC AGENT FOR AUTOIMMUNE DISEASE
#725Methods of treating a diabetic embryopathy
#726Compositions for Protein Delivery and Methods of Use Thereof
#727Administration of extracts of nonfruiting nonphotosynthetic filamentous bacteria for increasing the endogenous synthesis of superoxide dismutase
#728ANTIMICROBIAL THERAPY
#729COMPOSITIONS AND METHODS FOR MODULATING S-NITROSOGLUTHIONE REDUCTASE
#730USE OF URATE OXIDASE FOR THE TREATMENT OR PROPHYLAXIS OF DISORDERS OR INDIRECT SEQUELAE OF THE HEART CAUSED BY ISCHEMIC OR REPERFUSION EVENTS
#731Treatments involving glutaredoxins and similar agents
#732In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#733Methods for treating cone dystrophy with neuronal viability factor, RDCVF2
#734In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#735PROMOTING ECM PRODUCTION BY FIBROBLAST CELLS AND/OR PROMOTING MIGRATION OF FIBROBLAST CELLS IN A BIOLOGICAL SYSTEM
#736PHARMACEUTICALS AND METHODS FOR TREATING HYPOXIA AND SCREENING METHODS THEREFOR
#737Methods and compositions for treatment of lesioned sites of body vessels
#738PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING RESTENOSIS COMPRISING PEROXIREDOXIN 2 PROTEIN AS AN ACTIVE INGREDIENT AND COMPOSITION FOR SCREENING THERAPEUTICS OF RESTENOSIS COMPRISING PEROXIREDOXIN 2 GENE OR ITS PROTEIN PRODUCT, AND METHOD FOR SCREENING TH
#739Osteogenesis promoter
#740USE OF HYDROLYTIC AND OXIDATIVE ENZYMES TO DISSOLVE BIOFILM IN EARS
#741USE OF A GALANIN PEPTIDE AS A THERAPEUTIC AGENT
#742USES OF THIOREDOXIN
#743Therapeutic composition produced using punica granatum and hydrogen peroxide
#744METHODS OF USING BENFOTIAMINE AND PYRIDOXAMINE COMPOSITIONS
#745Compositions and methods for enzymatic treatment of lung disorders
#746Use of IL-1 antagonists to treat gout
#747METHODS AND COMPOSITIONS FOR THE TREATMENT OF VAGINAL DISEASES EMPLOYING PEROXIDE-PRODUCING ENZYMES AND PEROXIDASES
#748Diagnosis and treatment of preeclampsia
#749MODULATION OF NITRIC OXIDE SIGNALING TO NORMALIZE TUMOR VASCULATURE
#750Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers.
#751SILK MICROSPHERES FOR ENCAPSULATION AND CONTROLLED RELEASE
#752STABILIZATION OF AQUEOUS COMPOSITIONS OF PROTEINS WITH DISPLACEMENT BUFFERS
#753ORAL DISINFECTANT, AND FOOD ADDITIVE COMPRISING THE DISINFECTANT
#754HYBRID PROTEIN THAT CONVERTS ARACHIDONIC ACID INTO PROSTACYCLIN
#755Agent for use in the case of fructose intolerance
#756PRODUCT AND PROCESS FOR LIQUEFACTION OF MUCUS OR SPUTUM
#757Treating glaucoma, cardiovascular diseases, and renal diseases
#758Antimicrobial peroxidase compositions
#759Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof
#760Preventive or Therapeutic Agent for Inflammatory Ocular-Surface Diseases
#761Antimicrobial peracid compositions with selected catalase enzymes and methods of use in aseptic packaging
#762Antioxidant polymer nanocarriers for use in preventing oxidative injury
#763No-modified hemoglobins and uses therefor
#764PEROXIREDOXIN DRUGS FOR TREATMENT OF HIV-1 INFECTION AND METHODS OF USE THEREOF
#765In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
#766METHOD FOR CONTROLLING NAD(P)/NAD(P)H RATIO BY OXIDOREDUCTASE
#767ISOLATED STROMAL CELLS FOR USE IN THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM
#768Variant form of urate oxidase and use thereof
#769TARGETED THERAPEUTIC PROTEINS
#770CASCADE
#771Mycobacterial Catalase-Peroxidase in the Diagnosis and Treatment of Sarcoidosis
#772Screening method, a composition comprising substances chosen in the method thereof, and a binding substance
#773Variant forms of urate oxidase and use thereof
#774USE OF HAPTOGLOBIN GENOTYPING IN DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASE
#775Use of IL-1 antagonists to treat gout
#776Use of a Mixture of Superoxide Dismutase and Catalase for Treating Inflammatory Skin Lesions
#777Treatment to aid in the metabolism of alcohol
#778MODULATION OF CELL FATES AND ACTIVITIES BY PHTHALAZINEDIONES
#779DISSOLUTION OF ARTERIAL PLAQUE
#780Method for targeting lysosomal enzymes
#781HIFαprolyl hydroxylation assay
#782Modulation of cell fates and activities by phthalazinediones
#783PHARMACEUTICAL COMPOSITION, FOOD OR DRINK, OR FEED FOR INTESTINAL DISEASE
#784Treatment using herpes simplex virus
#785Methods and Compositions for Reducing Oxalate Concentrations
#786Method of skin treatment for rosacea using epidermal growth factor
#787Method to Reduce Oxalate Concentration by Administration of Oxalate Oxidase Crystals
#788Use of salicylaldehyde isonicotinoyl hydrazone (SIH) for protection against retinal disease
#789Stable Aqueous Suspension
#790Use of the Pro-Peptide Domain of Lysyl Oxidase as a Therapeutic Agent
#791Compositions containing lysozyme and C-1/C-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology
#792Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
#793Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
#794Synergistic preservative systems and their use in topical compositions
#795Compositions and methods for modulating S-nitrosoglutathione reductase
#796Novel Indications for Transforming Growth Factor-Beta Regulators
#797Methods of Diagnosing, Preventing, and Treating Early Onset of Pulmonary Hypertension
#798Diaminooxidase-Containing Pharmaceutical Compositions
#799SYSTEM, DEVICES, AND METHODS FOR IONTOPHORETIC DELIVERY OF COMPOSITIONS INCLUDING ANTIOXIDANTS ENCAPSULATED IN LIPOSOMES
#800Interleukin-6 suppressive agent
#801Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
#802Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity
#803Method of skin care and/or treatment using glutaredoxin
#804Methods For Lowering Hif-1 Mediated Gene Expression
#805Vitamin E supplementation for reducing cardiovascular events in individuals with DM and the Hp 2-2 genotype
#806WOUND HEALING COMPOSITIONS AND METHODS USING TROPOELASTIN AND LYSYL OXIDASE
#807Product and process for liquefaction of mucus or sputum
#808Method for treatment of neurodegenerative diseases and the effects of aging
#809Pharmaceutical composition for preventing and treating restenosis comprising peroxiredoxin 2 protein as an active ingredient and composition for screening therapeutics of restenosis comprising peroxiredoxin 2 gene or its protein product, and method for screening therapeutics of restinosis using said composition
#810Uses of Erss Modulators
#811NO-modified hemoglobins and uses therefor
#812Method of Killing Spores
#813Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
#814Preparation for preventing or treating disorders caused by toxic constituents contained in fiber combustion smoke
#815Methods of treatment with renalase (monoamine oxidase C)
#816Methods and compositions for treatment of lesioned sites of body vessels
#817Administration of extracts of nonfruiting nonphotosynthetic filamentous bacteria for increasing the endogenous synthesis of superoxide dismutase
#818Growth factor for hair and skin treatment
#819Compositions comprising conditioned cell culture media and uses thereof
#820Skin treatment preparation
#821Compositions and methods for oxalate reduction
#822Dairy components effective for fat loss
#823Systems and methods related to degradation of uremic toxins
#824Augmentation of intraluminal microvessel formation to facilitate guide wire crossing in chronic total occlusions
#825Internal medical devices containing peroxide-converting catalysts
#826Peptide-tagged proteins and methods of making and using thereof
#827Method of Treating Cancer
#828Modulation of cell fates and activities by phthalazinediones
#829Drug-delivering composite structures
#830Complexing agents for compositions containing inclusion complexes
#831Novel methods and medicament for treating infectious diseases involving microbial biofilms
#832Receptor antagonists as therapeutic agents for iNOS generating illness
#833Gels for encapsulation of biological materials
#834Matrices for drug delivery and methods for making and using the same
#835Compositions and methods relating to reduction of symptoms of autism
#836Method of treating neurological diseases
#837Methods of delivering therapeutics to the brain
#838Reduction in myocardial infarction size
#839Vector mediated organelle transfection
#840Method for preventing or delaying the onset of diabetes
#841Method and ophthalmic formulation for eye protection or treatment
#842Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy
#843Co-grafts for treating Parkinson's disease
#844Antitumor agents
#845Methods and uses of leukotriene Bhydroxylases to treat diseases
#846Means and methods for counteracting fatty acid accumulation
#847Osteogenesis promoter
#848Method for mass production of human pollicle stimulating hormone
#849Treatment of dry eye restoring 15-lipoxygenase activity to ocular surface cells
#850Compositions and methods for the treatment of leukemia
#851Compositions containing inclusion complexes
#852Enzymatic treatment of retinitis pigmentosis
#853Wound dressings containing an enzyme therapeutic agent
#854Antioxidant polymer nanocarriers for use in preventing oxidative injury
#855Agent for treatment of inflammatory bowel disease
#856Peroxiredoxin drugs for treatment of HIV-1 infection and methods of use thereof
#857Conditioned medium of autologous or allogenic progenitor cells for angiogenesis treatment
#858Composition for treatment of oily skin and acne prevention and methods of making and using same
#859Injection of bone marrow-derived conditioned medium for angiogenesis
#860Topical compositions comprising benfotiamine and pyridoxamine
#861Bioprosthetic heart valves
#862Cutanceous metabolic bio-activator
#863Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
#864Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation
#865Use of histamine and related compounds to treat disorders affecting muscle function
#866Modulation of cell fates and activities by phthalazinediones
#867Biliverdin reductase fragments and variants, and methods of using biliverdin reductase and such fragments and variants
#868Mucolytic and anti-elastase compounds and methods of use thereof
#869Cosmetic skin formulation
#870Interleukin-6 suppressive agent
#871Use of hyrogen peroxide producting enzyme for treatment of otitis media
#872Compositions containing internally activated antioxidant
#873Thioredoxin increases redox-cycling of anticancer agents thereby sensitizes cancer cells to apoptosis
#874Indole-3-acetic acid derivatives
#875Eosinophil Major Basic Protein as a natural heparanase-inhibiting protein, compositions, methods and uses thereof
#876Method of delaying the onset of diabetes
#877Pharmaceuticals and methods for treating hypoxia and screening methods therefor
#878Wound healing compositions and methods using tropoelastin and lysyl oxidase
#879Methods of treating amino acid metabolic disorders using recombinant adeno-associated virus virions
#880Therapy of diseases of the eye, the inner ear and the central nervous system
#881Systems and methods related to degradation of uremic toxins
#882Presbyopia treatment by lens alteration
#883Method for killing spores
#884Method of treatment of endothelial dysfunction and engineered proteins for same
#885Methods of treating xerostomia and xerophthalmia
#886Compositions and methods for preventing and treating liver cirrhosis
#887Compositions and methods of treating diabetes
#888Compositions and methods for modulating S-nitrosoglutathione reductase
#889Family of heme binding proteins that increase chelated iron content and improve flavor of nutritional supplements and food products